Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjustable versus standard brodalumab dosing in high-body-weight plaque psoriasis
2017-004998-13Phase 4Active
- Sponsor
- LEO Pharma
- Start
- Apr 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised trial of brodalumab in plaque psoriasis (2 arms), sponsored by LEO Pharma. Started Apr 2020; status: active.
02
Drugs
brodalumab
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on 2017-004998-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004998-13.